Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology · Behavioral variant frontotemporal dementia

Symptoms and the Rascovsky Criteria

At a Glance

Behavioral variant frontotemporal dementia (bvFTD) is diagnosed using the Rascovsky criteria, which focus on six core personality and behavior changes. Because it alters behavior before memory, it is often misdiagnosed as depression, but specialized tests can reveal the difference.

Diagnosing behavioral variant frontotemporal dementia (bvFTD) is notoriously complex because the disease affects behavior and personality long before it affects memory. Because these symptoms look so much like mental health issues, many patients are initially misdiagnosed with psychiatric disorders [1][2]. To help doctors navigate this, they use the Rascovsky criteria, a standardized checklist of symptoms and testing results [3].

The Six Core Symptoms (Rascovsky Criteria)

To be considered for a diagnosis, a person must show three of the following six symptoms. In bvFTD, these changes usually appear early and represent a clear departure from the person’s lifelong personality [1][4].

  1. Disinhibition: This is a loss of social “brakes.” It may manifest as impulsive spending, making offensive or inappropriate comments, or a sudden lack of manners [5][6].
  2. Apathy or Inertia: This is the most common symptom, occurring in over 50% of cases [7]. It looks like a total loss of drive or interest. The person may sit for hours doing nothing and require constant prompting to start basic tasks like showering or eating [8].
  3. Loss of Sympathy or Empathy: The person may seem cold or indifferent to the feelings of others. They might not react when a loved one is hurt or crying, or they may lose interest in long-standing relationships [9][10].
  4. Repetitive or Compulsive Behaviors: This includes “stereotyped” behaviors like pacing, repeating the same phrase, or performing elaborate rituals (like checking locks or organizing items) [7][11].
  5. Hyperorality and Dietary Changes: Patients often develop a “sweet tooth” or binge eat. In severe cases, they may try to consume non-food objects (e.g., eating raw meat, coffee grounds, or napkins). There may also be a sudden increase in smoking or alcohol use [12][13].
  6. Executive Dysfunction: On cognitive tests, the person struggles with planning, organization, and multi-tasking (executive function), while their memory and ability to navigate their surroundings (visuospatial skills) often remain surprisingly normal in the early stages [14][15].

Levels of Diagnostic Certainty

Doctors use three categories to describe how certain they are of the diagnosis [3]:

  • Possible bvFTD: The person meets at least three of the six core clinical symptoms listed above.
  • Probable bvFTD: The person meets the “possible” criteria AND has imaging (MRI or PET scan) that shows shrinkage (atrophy) or low activity in the frontal or temporal lobes [16].
  • Definite bvFTD: This is only confirmed through a brain biopsy, post-mortem examination, or the discovery of a known genetic mutation associated with the disease [3][17].

The Misdiagnosis Trap

Because bvFTD symptoms like apathy and disinhibition overlap so heavily with Major Depressive Disorder, Bipolar Disorder, and Schizophrenia, misdiagnosis is common [1][18]. Families often spend years treating a “psychiatric illness” that doesn’t improve with therapy or medication.

Feature Psychiatric Disorder (e.g., Depression/Bipolar) bvFTD
Progression Often comes in cycles (episodes) or stays stable [19]. Relentless and steady decline over time [20].
Response to Treatment Often improves with psychiatric medications [20]. Symptoms rarely respond to standard psychiatric drugs [1].
Physical Markers Brain scans and blood tests are typically normal [2]. Neurofilament Light (NfL) levels in the blood are often high [21].
Brain Imaging No physical shrinkage seen on MRI [2]. MRI often shows shrinkage in frontal/temporal lobes [22].

If a “psychiatric” condition is not responding to treatment and behavior continues to decline, it is critical to advocate for specialized testing like an NfL blood test or an FDG-PET scan [21][23].

Return to Home Page

Common questions in this guide

What are the Rascovsky criteria for bvFTD?
The Rascovsky criteria are a standardized checklist doctors use to diagnose behavioral variant frontotemporal dementia. They include six core symptoms: disinhibition, apathy, loss of empathy, repetitive behaviors, dietary changes, and executive dysfunction.
Why is bvFTD often misdiagnosed as depression or bipolar disorder?
Because bvFTD affects personality and behavior long before it affects memory, early symptoms look very similar to psychiatric conditions. However, unlike psychiatric disorders, bvFTD involves a steady physical decline over time and rarely improves with standard psychiatric medications.
How can a doctor tell the difference between bvFTD and Alzheimer's disease?
In the early stages of bvFTD, a patient's memory and ability to navigate their surroundings usually remain normal, whereas these are typically the first areas affected in Alzheimer's disease. A doctor will also look for specific behavioral changes and brain shrinkage in the frontal and temporal lobes.
What tests are used to confirm a bvFTD diagnosis?
Doctors use imaging tests like MRI or PET scans to check for brain shrinkage in the frontal or temporal lobes, which increases diagnostic certainty. A Neurofilament Light (NfL) blood test can also help distinguish a neurodegenerative disease from a psychiatric condition.
What kind of dietary changes happen with bvFTD?
Patients often experience hyperorality, which can include developing a sudden craving for sweets or binge eating. In more severe cases, individuals may attempt to eat non-food objects like raw meat, coffee grounds, or napkins.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does the patient meet the criteria for 'possible' or 'probable' bvFTD based on the Rascovsky criteria?
  2. 2.How can we distinguish apathy from clinical depression, especially if there is no response to antidepressants?
  3. 3.Given a previous psychiatric diagnosis, what specific clinical signs now point toward a neurodegenerative cause like FTD?
  4. 4.Can we perform a Neurofilament Light (NfL) blood test or a PET scan to clarify the diagnosis?
  5. 5.If memory and spatial skills are currently normal, does that help confirm a bvFTD diagnosis over Alzheimer's?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    The Neuropsychiatric Features of Behavioral Variant Frontotemporal Dementia.

    Peet BT, Castro-Suarez S, Miller BL

    Advances in experimental medicine and biology 2021; (1281()):17-31 doi:10.1007/978-3-030-51140-1_2.

    PMID: 33433866
  2. 2

    Behavioral variant frontotemporal dementia in patients with primary psychiatric disorder: A magnetic resonance imaging study.

    Tafuri B, Filardi M, Frisullo ME, et al.

    Brain and behavior 2023; (13(4)):e2896 doi:10.1002/brb3.2896.

    PMID: 36864745
  3. 3

    [New entities and the criteria of FTLD].

    Otsuki M

    Nihon rinsho. Japanese journal of clinical medicine 2016; (74(3)):459-65.

    PMID: 27025087
  4. 4

    Psychological and Cognitive Markers of Behavioral Variant Frontotemporal Dementia-A Clinical Neuropsychologist's View on Diagnostic Criteria and Beyond.

    Johnen A, Bertoux M

    Frontiers in neurology 2019; (10()):594 doi:10.3389/fneur.2019.00594.

    PMID: 31231305
  5. 5

    Social Cognition in Behavioral Variant Frontotemporal Dementia and Pathological Subtypes: A Narrative Review.

    Dilcher R, Malpas CB, O'Brien TJ, Vivash L

    Journal of Alzheimer's disease : JAD 2023; (94(1)):19-38 doi:10.3233/JAD-221171.

    PMID: 37212100
  6. 6

    Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia.

    Morrow CB, Kamath V, Dickerson BC, et al.

    Psychiatry and clinical neurosciences 2025; (79(6)):327-335 doi:10.1111/pcn.13810.

    PMID: 40079430
  7. 7

    Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration.

    Kawakami I, Arai T, Shinagawa S, et al.

    International journal of geriatric psychiatry 2021; (36(1)):38-45 doi:10.1002/gps.5387.

    PMID: 32748432
  8. 8

    Apathy and Disinhibition Related to Neuropathology in Amnestic Versus Behavioral Dementias.

    Borges LG, Rademaker AW, Bigio EH, et al.

    American journal of Alzheimer's disease and other dementias 2019; (34(5)):337-343 doi:10.1177/1533317519853466.

    PMID: 31170813
  9. 9

    Moral processing deficit in behavioral variant frontotemporal dementia is associated with facial emotion recognition and brain changes in default mode and salience network areas.

    Van den Stock J, Stam D, De Winter FL, et al.

    Brain and behavior 2017; (7(12)):e00843 doi:10.1002/brb3.843.

    PMID: 29299378
  10. 10

    The impact of sex on clinical profiles of patients with behavioral variant frontotemporal dementia.

    Afrooz P, St-Georges MA, Carrier T, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2025; (21(12)):e70996 doi:10.1002/alz.70996.

    PMID: 41457063
  11. 11

    Neuropsychiatric Symptoms Cluster and Fluctuate Over Time in Behavioral Variant Frontotemporal Dementia.

    Morrow CB, Kamath V, Dickerson BC, et al.

    medRxiv : the preprint server for health sciences 2024; doi:10.1101/2024.09.26.24314180.

    PMID: 39398998
  12. 12

    Young-onset frontotemporal dementia with FUS pathology.

    Gowell M, Baker I, Ansorge O, Husain M

    Practical neurology 2020; doi:10.1136/practneurol-2020-002730.

    PMID: 33310885
  13. 13

    Hyperorality in Frontotemporal Dementia: How Psychiatric and Neural Correlates Change During the Disease Course.

    Morrow CB, Onyike C, Pantelyat A, et al.

    The Journal of neuropsychiatry and clinical neurosciences 2026; (38(1)):31-37 doi:10.1176/appi.neuropsych.20240134.

    PMID: 40134270
  14. 14

    Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.

    Ljubenkov PA, Staffaroni AM, Rojas JC, et al.

    Annals of clinical and translational neurology 2018; (5(10)):1250-1263 doi:10.1002/acn3.643.

    PMID: 30349860
  15. 15

    Speech and language impairments in behavioral variant frontotemporal dementia: A systematic review.

    Geraudie A, Battista P, García AM, et al.

    Neuroscience and biobehavioral reviews 2021; (131()):1076-1095 doi:10.1016/j.neubiorev.2021.10.015.

    PMID: 34673112
  16. 16

    Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.

    Vijverberg EG, Wattjes MP, Dols A, et al.

    Journal of Alzheimer's disease : JAD 2016; (53(4)):1287-97 doi:10.3233/JAD-160285.

    PMID: 27372646
  17. 17

    Progression in Behavioral Variant Frontotemporal Dementia: A Longitudinal Study.

    Devenney E, Bartley L, Hoon C, et al.

    JAMA neurology 2015; (72(12)):1501-9 doi:10.1001/jamaneurol.2015.2061.

    PMID: 26501846
  18. 18

    Frontotemporal dementia.

    Bang J, Spina S, Miller BL

    Lancet (London, England) 2015; (386(10004)):1672-82.

    PMID: 26595641
  19. 19

    The Diagnostic Landscape of Behavioral Variant Frontotemporal Dementia.

    Barker MS, Manoochehri M, Huey ED

    Rhode Island medical journal (2013) 2025; (108(5)):17-22.

    PMID: 40300053
  20. 20

    Late life bipolar disorder evolving into frontotemporal dementia mimic.

    Dols A, Krudop W, Möller C, et al.

    Neuropsychiatric disease and treatment 2016; (12()):2207-12 doi:10.2147/NDT.S99229.

    PMID: 27660450
  21. 21

    Biofluid biomarkers in distinguishing young-onset dementia from primary psychiatric disorders.

    Loi SM, Eratne D, Santillo AF, Velakoulis D

    Current opinion in psychiatry 2025; (38(2)):134-143 doi:10.1097/YCO.0000000000000979.

    PMID: 39887317
  22. 22

    VentRa: distinguishing frontotemporal dementia from psychiatric disorders.

    Manera AL, Dadar M, Ducharme S, Collins DL

    Brain communications 2024; (6(2)):fcae069 doi:10.1093/braincomms/fcae069.

    PMID: 38510209
  23. 23

    Data-driven analysis of regional brain metabolism in behavioral frontotemporal dementia and late-onset primary psychiatric diseases with frontal lobe syndrome: A PET/MRI study.

    Cagnin A, Pigato G, Pettenuzzo I, et al.

    Neurobiology of aging 2024; (137()):47-54 doi:10.1016/j.neurobiolaging.2024.01.015.

    PMID: 38422798

This page provides information on bvFTD symptoms and diagnostic criteria for educational purposes only. It does not replace professional medical evaluation by a neurologist or specialist.

Get notified when new evidence is published on Behavioral variant of frontotemporal dementia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.